Literature DB >> 2536386

Detection of human papillomaviruses in exfoliated cervicovaginal cells by in situ DNA hybridization analysis.

C C Pao1, C H Lai, S Y Wu, K C Young, P L Chang, Y K Soong.   

Abstract

A total of 851 specimens of exfoliated cervicovaginal cells and 27 specimens of male urethral smears obtained from 706 individuals with various clinical findings were examined for the presence of human papillomavirus (HPV) types 6, 11, 16, 18, 31, and 33 by in situ DNA hybridization analysis. The nonradioactive DNA in situ hybridization method used in this study showed no detectable cross-hybridization either among different types of HPV (except between types 6 and 11) or between HPV DNA and human cellular DNA. Furthermore, this system was found to be more sensitive than the Southern blotting method in detecting HPV. HPV was found in 233 of 276 (84.4%) and in 34 of 47 (72.3%) samples of cervicovaginal cells from patients with urogenital condylomata and cervical dysplasia, respectively. HPV was also detected in 6 of 39 (15.4%) women with normal cytological findings who were also symptom-free. Young women who were at low risk but were infected with HPV showed significantly reduced ratios of helper-inducer T lymphocytes to suppressor-cytotoxic T lymphocytes compared with those of uninfected normal controls (1.28 +/- 0.31 versus 2.47 +/- 0.64; P less than 0.001). This in situ DNA hybridization method can have broad application to the screening of HPV in early lesions and in normal-looking tissues and may be used to identify patients at risk of more serious or possibly malignant progression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536386      PMCID: PMC267254          DOI: 10.1128/jcm.27.1.168-173.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Evaluation of different DNA-DNA hybridisation techniques in detection of HPV 16 DNA in cervical smears and biopsies.

Authors:  M T Cornelissen; K J van der Velden; J M Walboomers; M A Briët; H L Smits; J van der Noordaa; J ter Schegget
Journal:  J Med Virol       Date:  1988-05       Impact factor: 2.327

2.  Human papillomavirus frequency in normal cervical tissue.

Authors:  L Gergely; J Czeglédy; Z Hernády
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

3.  Prospective evaluation of risk of cervical cancer after cytological evidence of human papilloma virus infection.

Authors:  H Mitchell; M Drake; G Medley
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

4.  Non-invasive detection of cervical papillomavirus DNA.

Authors:  D J McCance; M J Campion; A Singer
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Gynecologic malignancies in immunosuppressed organ homograft recipients.

Authors:  R Porreco; I Penn; W Droegemueller; B Greer; E Makowski
Journal:  Obstet Gynecol       Date:  1975-04       Impact factor: 7.661

6.  Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia.

Authors:  S Sato; T Okagaki; B A Clark; L B Twiggs; M Fukushima; R S Ostrow; A J Faras
Journal:  Int J Gynecol Pathol       Date:  1986       Impact factor: 2.762

7.  Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

Authors:  P G Toon; J R Arrand; L P Wilson; D S Sharp
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-15

8.  Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome.

Authors:  L F Carson; L B Twiggs; M Fukushima; R S Ostrow; A J Faras; T Okagaki
Journal:  Am J Obstet Gynecol       Date:  1986-10       Impact factor: 8.661

9.  DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland.

Authors:  D W Millan; J A Davis; T E Torbet; M S Campo
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

10.  Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix.

Authors:  A T Lörincz; G F Temple; J A Patterson; A B Jenson; R J Kurman; W D Lancaster
Journal:  Obstet Gynecol       Date:  1986-10       Impact factor: 7.661

View more
  5 in total

1.  Comparative analysis of human papillomavirus detection by dot blot hybridisation and non-isotopic in situ hybridisation.

Authors:  G Troncone; S M Anderson; C S Herrington; M L de Angelis; H Noell; J A Chimera; J O'D McGee
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

2.  Prevalence of genital human papillomavirus infections in patients at a sexually transmitted diseases clinic.

Authors:  Y L Chang; C Y Lin; C J Tseng; H S Cheng; H C Lin; C C Pao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

3.  Detection of human papillomavirus in cervical scrapings by in situ hybridization and the polymerase chain reaction in relation to cytology.

Authors:  M Ramael; K Segers; N Pannemans; F Wesling; E Van Marck
Journal:  Histochem J       Date:  1995-01

4.  Detection of high risk human papillomavirus in routine cervical smears: strategy for screening.

Authors:  C S Herrington; M de Angelis; M F Evans; G Troncone; J O McGee
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

5.  Detection of human papillomavirus in matched cervical smears and biopsy specimens by non-isotopic in situ hybridisation.

Authors:  G Troncone; C S Herrington; K Cooper; M L de Angelis; J O McGee
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.